Sunday Audu

Dr. Sunday Audu

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2026 in Vaccines
Verified
Journal Article
Open access
PDF file
WXWei Xia
Wei Xia
SYSoofia Yunus
Soofia Yunus
ARatta Ur Rehman
atta Ur Rehman
SJShah Nawaz Jiskani
Shah Nawaz Jiskani
MQMuhammad Imran Qureshi
Muhammad Imran Qureshi
RKRozina Khalid
Rozina Khalid
Background: The International Agency for Research on Cancer estimated around 3197 annual deaths along with 5008 newly diagnosed cases of cervical cancer in Pakistan. Worldwide, introduced in 164 WHO member states, the HPV vaccine provides over ninety percent (90%) protection from human papillomavirus (16 & 18 types) infections. This article intended to document the vaccine (HPV) introduction in a low-middle-income country through the lens of EPI preparedness, vaccination coverage achieved, community acceptance, and implementation challenges during Phase I. Methodology: The research applied a qualitative and quantitative mix method to review the intricate procedure of new vaccine rollout within the national context. A qualitative participant observation approach assessed the planning, approval, and implementation phases of the HPV vaccine. Quantitative data statistics were evaluated for national & regional vaccination coverages, rapid convenience assessment findings, and adverse events reports. Results: The overall reported administrative HPV campaign coverage was 75%, with the maximum regional coverage of 81% by the Punjab, followed by 66% of the Sindh, 43% by the Azad Jammu & Kashmir, and 38% by the Islamabad. Rapid Convenience Assessment findings highlighted the main reasons for refusal (71%), with unavailable girls during the campaign (22%) for non-HPV vaccination. Community acceptance varied across the regions, with notable challenges in implementation being observed. Discussion & Way Forward: Initial phase campaign coverage (70.6%) was greater than the worldwide reported first dose mean coverage (61.6%) for the same multi-age cohort, indicative of an encouraging start in resource limited setting. Documented coverage was below the high-performing countries but comparable to multiple low and middle-income countries. Federal Directorate of Immunization, in collaboration with provincial EPI stakeholders, should prioritize including the newly introduced HPV vaccine in the routine immunization schedule of the Phase I regions and should also implement the lessons learned in the subsequent rollout phases in 2026 in Khyber Pakhtunkhwa and 2027 in Balochistan & Gilgit Baltistan. Expanding fixed EPI sites for HPV vaccination, promoting school-centered vaccination, rationalizing outreach in marginalized areas, sustaining the cold chain system, implementing a culturally acceptable communication plan, and resolving internet connectivity challenges are the key strategies to address implementation challenges.

21 December 2023 in African Journal of Primary Health Care & Family Medicine
Verified
Journal Article
Open access
PDF file
NBNuhu N. Butawa
Nuhu N. Butawa
ANAwawu G. Nmadu
Awawu G. Nmadu
SASunday Audu
Sunday Audu
FAFidelis O. Ajuonuma
Fidelis O. Ajuonuma
KHKhadeejah L. Hamza
Khadeejah L. Hamza
SUSuleiman Usman
Suleiman Usman
Background: People who inject drugs (PWID) are known to have higher rates of mental health disorders, particularly depression. Despite this, there is a lack of research on the prevalence of depression among PWID in Nigeria. Aim: This study aimed to determine the prevalence of depressive symptoms and their determinants among PWID. Setting: The study was conducted in Kaduna State, Northwest Nigeria where a needle and syringe programme (NSP) for PWID was recently initiated. Methods: A cross-sectional survey was conducted among PWID using a multi-stage sampling technique. Data were collected using structured interviews and digitalised questionnaires covering socio-demographics, depression symptoms (PHQ-9) and perceived social support (MSPSS). Results: A total of 525 participants were included in the study, with the majority being males (73.3%) aged 24–35 years (54.5%). The study revealed a high prevalence of depressive symptoms among PWID, with 47.4% reporting major symptoms. Predictors of depression identified among PWID included older age, female gender, divorce, unemployment, having primary education and moderate social support. Conclusion: The study underscored a concerning prevalence of depressive symptoms among PWID, notably linked to diverse sociodemographic factors, emphasising the need for holistic, context-specific mental healthcare approaches for this population. Contribution: This study contributes to the limited research on the mental health of PWID in Nigeria. It highlights the need for targeted mental health interventions that consider the unique sociodemographic characteristics of this population.

6 July 2023 in medRxiv
Verified
Preprint
Open access
PDF file
GUGregory C. Umeh
Gregory C. Umeh
LKLaurent Cleenwerck de Kiev
Laurent Cleenwerck de Kiev
JMJabani Mamza
Jabani Mamza
AAAliyu Atiku
Aliyu Atiku
SMSuleiman Mohammed
Suleiman Mohammed
ABAmina Mohammed Baloni
Amina Mohammed Baloni
Background: The novel SARS-CoV-2 virus that causes Coronavirus disease (COVID-19) has redefined global health and response to Acute Respiratory Infection (ARI). The outbreak of a cluster of influenza-like illnesses in Wuhan, China, has morphed into a pandemic in the last quarter of 2019, stretching from South East Asia to Europe, The Americas, Africa, and the Australian subcontinent. Materials and Methods: We shall utilize a cross-sectional, observational design to investigate the prevalence of symptoms of depression among outpatients with ARI and describe the characteristics of outpatients with ARI in Kaduna State. Results: The prevalence of symptoms of depression was 19.6% for respondents with symptoms of ARI, and 14.4%, for those without symptoms of ARI. On no risk of depression, we had a higher proportion of the respondents without symptoms of ARI (86%) than those with symptoms of depression (80%) (M=318.4, SD=29.62 case, and M=344.0, SD=14.2 control, r=0.88, CI=13.5 to 6.5, P=0.000952). Likewise, in the category with mild risk of depression, respondents without symptoms of ARI were fewer (10%) than those with symptoms of depression (15%) (M=58.4, SD=26.0 case, and M=42.1, SD=12.7 control, r=0.86, CI=11.8 to 5.8, P=0.0136. There was no significant difference between respondents with symptoms of ARI and without symptoms of ARI in the categories of moderate (M=13.6, SD=5.1 case, and M=11.6, SD=4.6 control, r=0.87, CI=2.3 to 2.1, P=0.178) and high (M=5.6, SD=2.5 case, and M=4.4, SD=3.2 control, r=0.61, CI=1.2 to 1.5, P=0.174) risk of depression. Conclusion: Symptoms of depression were commoner among respondents who presented with symptoms of Acute Respiratory Infection (ARI) at the Outpatient Department (OPD). However, further explanatory research is needed to establish causality.

16 May 2024 in PLOS ONE
Verified
Journal Article
Open access
PDF file
GUGregory C. Umeh
Gregory C. Umeh
LKLaurent Cleenwerck de Kiev
Laurent Cleenwerck de Kiev
JMJabani Mamza
Jabani Mamza
AAAliyu Atiku
Aliyu Atiku
SMSuleiman Mohammed
Suleiman Mohammed
ABAmina Mohammed Baloni
Amina Mohammed Baloni
Background: The novel SARS-CoV-2 virus that causes Coronavirus disease (COVID-19) has redefined global health and response to Acute Respiratory Infection (ARI). The outbreak of a cluster of influenza-like illnesses in Wuhan, China, has morphed into a pandemic in the last quarter of 2019, stretching from South East Asia to Europe, The Americas, Africa, and the Australian subcontinent. We evaluated the prevalence of depression among outpatients diagnosed with ARI. Materials and methods: We utilized a cross-sectional, observational design and investigated the prevalence of symptoms of depression among outpatients with ARI and described the characteristics of outpatients with ARI in Kaduna State. Results: The prevalence of symptoms of depression was 19.6% for respondents with symptoms of ARI and 14.4% for those without symptoms of ARI. On no risk of depression, we had a higher proportion of the respondents without symptoms of ARI (86%) than those with symptoms of depression (80%) (M = 318.4, SD = 29.62 case, and M = 344.0, SD = 14.2 control, r = 0.88, CI = 13.5 to 6.5, P = 0.000952). Likewise, in the category with mild risk of depression, respondents without symptoms of ARI were fewer (10%) than those with symptoms of depression (15%) (M = 58.4, SD = 26.0 case, and M = 42.1, SD = 12.7 control, r = 0.86, CI = 11.8 to 5.8, P = 0.0136. There was no significant difference between respondents with symptoms of ARI and without symptoms of ARI in the categories of moderate (M = 13.6, SD = 5.1 case, and M = 11.6, SD = 4.6 control, r = 0.87, CI = 2.3 to 2.1, P = 0.178) and high (M = 5.6, SD = 2.5 case, and M = 4.4, SD = 3.2 control, r = 0.61, CI = 1.2 to 1.5, P = 0.174) risk of depression. Conclusion: Symptoms of depression were commoner among respondents who presented with symptoms of Acute Respiratory Infection (ARI) at the Outpatient Department (OPD). However, further explanatory research is needed to establish causality.

1 January 2026 in Decoding Infection and Transmission
Verified
Journal Article
Open access
UIUsman Muhammad Ibrahim
Usman Muhammad Ibrahim
BKBoateng Kofi
Boateng Kofi
SBSalisu Muazu Babura
Salisu Muazu Babura
SASunday Audu
Sunday Audu
ADAbba Ahmed Danzomo
Abba Ahmed Danzomo
AJAbubakar Mohammed Jibo
Abubakar Mohammed Jibo